Showing results (51-60 of 135) with videos related to

Sort By:
Pageof 14
Investigational New Drugs|December 5, 2022
Ocular toxicity of investigational anti-cancer drugs in early phase clinical trialsShigemasa Takamizawa, Yuki Katsuya, Yi-Ning Chen, et al.
Japanese Journal of Clinical Oncology|October 16, 2019
Identification of serum microRNAs predicting the response of esophageal squamous-cell carcinoma to nivolumabKazuki Sudo, Ken Kato, Juntaro Matsuzaki, et al.
Japanese Journal of Clinical Oncology|April 24, 2023
Clinical characteristics of primary cutaneous and subcutaneous Ewing sarcomaHisaki Aiba, Yuki Kojima, Tatsunori Shimoi, et al.
Cancer Medicine|March 11, 2024
Incidence of skeletal-related events in patients with Ewing sarcoma: An observational retrospective study in JapanHisaki Aiba, Yuki Kojima, Tatsunori Shimoi, et al.
JAMA Network Open|May 25, 2019
Development and Validation of an Esophageal Squamous Cell Carcinoma Detection Model by Large-Scale MicroRNA ProfilingKazuki Sudo, Ken Kato, Juntaro Matsuzaki, et al.
Investigational New Drugs|February 9, 2021
A first-in-human, phase 1 study of the NEDD8 activating enzyme E1 inhibitor TAS4464 in patients with advanced solid tumorsNoboru Yamamoto, Toshio Shimizu, Kan Yonemori, et al.
Japanese Journal of Clinical Oncology|July 1, 2026
De-escalation of breast surgery for early stage breast cancerTakeshi Murata, Tomomi Fujisawa, Fumikata Hara, et al.
BMC Cancer|October 21, 2021
Hotspot mutation profiles of AKT1 in Asian women with breast and endometrial cancersTatsunori Shimoi, Jun Hashimoto, Kazuki Sudo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 10, 2021
Identification of novel SSX1 fusions in synovial sarcomaAkihiko Yoshida, Yasuhito Arai, Kaishi Satomi, et al.
Oncology|February 4, 2025
Treatment and Reasons for Choosing Treatment in Breast Cancer Patients Who Underwent Next-Generation Sequencing TestRumi Nishimura, Kazuki Sudo, Rui Kitadai, et al.
Pageof 14